It was recently reported that resolvin E1, a novel lipid mediator generated from eicosapentaenoic acid (EPA), activates factors that reduce inflammation.
Consequently, attempts to identify a novel lipid mediator generated from macrophages and challenges to define its actions and biosynthesis led to the discovery of a novel group of DHA-derived resolvents, maresins [ 99].
Similarly, the amount of stored mediators generated and released from mast cells and basophils is totally unknown.
Thus, the release of cfDNA from host cells occurred independent of the infecting organism and hence is likely mediated by the inflammatory mediators generated during the exacerbated host response to infection.
Dozens of different mediators have been identified including mediators released from mast cells and basophils, as well as mediators generated in the cascade of events that is activated by those cells (Wasserman, 2008; Gandhi et al., 2009).
Resolution of inflammation is an active process involving specialised pro-resolving mediators (SPMs) generated from the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Many signals can activate ECs and platelets in sepsis, including pathogens and mediators generated by inflammation and coagulation.
Mediators generated by cell damage such as complement activation products and histones can activate platelets [123, 124].
4 The endothelium is believed to be a primary target of mediators generated by the placenta.
Lymphocyte activation was probably secondary to phlogistic mediators generated in whole blood samples supplemented with bacteria.
